FDA Eyeing Study On Cosmetic Hair-Care/Hair-Loss Link
This article was originally published in The Rose Sheet
Executive Summary
Interested parties capable of conducting in vivo and in vitro tests "to study alopecia that may be associated with the use of commercially available cosmetic hair products and individual ingredients in these products" must respond to FDA's Sources Sought Notice by Feb. 26.
You may also be interested in...
DevaCurl Faces Multiple Class Actions As Latest Brand Linked To Hair Loss
The company maintains that its products are safe, but plaintiffs in proposed class actions allege it has knowingly put consumers at risk of hair loss and other injuries. DevaCurl’s troubles escalated quickly after a former brand ambassador went viral with a 31 January video urging consumers to stop using DevaCurl products and adopt safer alternatives.
Monat Offensive Fails To Deter Class Actions For Alleged Fraud, Hair Loss
Direct seller launched a preemptive strike last year against a professional stylist for her allegations that Monat hair products cause hair loss and other damage "just like WEN." In recent weeks, the firm has lodged more defamation suits against individuals, while plaintiffs have begun filing proposed class actions against Monat in Florida federal court
Monat Sues Former Sales Rep For 'Libelous' WEN-Like Allegations
The hair-care direct seller seeks injunctive relief and damages in a suit against a former sales rep who allegedly started the "Monat – My Modern Nightmare" Facebook group. According to Monat, there's no scientific or factual basis for defendant's claims that its products cause balding, hair loss and scalp damage.